US Stock MarketDetailed Quotes

ABEO Abeona Therapeutics

Watchlist

6.3900
-0.0200-0.31%

Close Nov 29 13:00 ET

277.78MMarket Cap-3117P/E (TTM)

Abeona Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-112.91%-12.23M

-23.34%-12.68M

-23.79%-14.54M

14.89%-37.01M

34.00%-9.24M

15.39%-5.75M

-14.10%-10.28M

14.20%-11.74M

33.78%-43.48M

53.76%-13.99M

Net income from continuing operations

-155.74%-30.27M

144.47%7.41M

-246.74%-31.58M

-36.51%-54.19M

-132.99%-16.59M

-83.96%-11.84M

-306.49%-16.65M

58.69%-9.11M

53.26%-39.7M

84.75%-7.12M

Operating gains losses

1,270.34%15.16M

-427.54%-24.93M

863.84%17.3M

218.29%10.68M

189.65%4.23M

136.44%1.11M

400.71%7.61M

-280.77%-2.27M

-413.42%-9.03M

---4.71M

Depreciation and amortization

-3.86%722K

-18.26%685K

-18.47%724K

-30.13%3.2M

-28.54%721K

-30.78%751K

-38.83%838K

-20.22%888K

2.53%4.58M

-15.64%1.01M

Other non cash items

69.65%531K

160.54%383K

1,782.35%286K

-8.99%324K

93.34%-119K

146.46%313K

110.88%147K

-100.50%-17K

105.43%356K

-2,568.66%-1.79M

Change In working capital

-107.53%-178K

177.64%2.45M

-39.94%-2.82M

69.65%-1.79M

125.35%1.02M

183.33%2.36M

-101.21%-3.15M

-74.29%-2.01M

67.74%-5.89M

79.11%-4M

-Change in receivables

-99.23%27K

110.10%552K

436.00%252K

-172.58%-2.04M

-102.33%-20K

97.64%3.52M

-93.28%-5.46M

-102.50%-75K

193.73%2.81M

128.63%859K

-Change in prepaid assets

-10.50%213K

40.52%593K

-2.75%-1.23M

-107.94%-155K

-26.30%384K

-51.92%238K

-24.37%422K

-416.36%-1.2M

490.03%1.95M

135.44%521K

-Change in payables and accrued expense

92.64%-79K

-29.07%1.57M

-349.47%-1.69M

122.41%2.04M

132.11%1.28M

6.20%-1.07M

215.10%2.21M

91.97%-376K

41.57%-9.11M

72.93%-3.98M

-Change in other current assets

138.71%12K

255.56%14K

391.07%163K

-287.20%-234K

-500.00%-138K

---31K

---9K

-137.84%-56K

1,885.71%125K

-243.75%-23K

-Change in other current liabilities

-21.88%-351K

10.83%-280K

-0.98%-310K

16.43%-1.4M

64.44%-490K

2.70%-288K

---314K

---307K

---1.67M

---1.38M

Cash from discontinued investing activities

Operating cash flow

-112.91%-12.23M

-23.34%-12.68M

-23.79%-14.54M

14.89%-37.01M

34.00%-9.24M

15.39%-5.75M

-14.10%-10.28M

14.20%-11.74M

33.78%-43.48M

53.76%-13.99M

Investing cash flow

Cash flow from continuing investing activities

67.10%-6.17M

-946.90%-44.13M

-453.55%-7.82M

100.87%208K

145.59%11.53M

-1,236.63%-18.74M

472.75%5.21M

105.67%2.21M

-136.28%-23.96M

-416.16%-25.29M

Capital expenditure reported

-818.18%-404K

-2,121.88%-711K

-232.57%-725K

-154.62%-331K

-48.00%-37K

-2,100.00%-44K

---32K

-111.65%-218K

96.87%-130K

99.23%-25K

Net PPE purchase and sale

--0

----

-88.24%204K

-88.19%17K

-92.23%8K

----

--1.73M

--144K

Net investment purchase and sale

69.19%-5.76M

-957.80%-43.44M

-391.97%-7.09M

101.31%335K

145.45%11.55M

-1,308.46%-18.71M

275.53%5.06M

106.20%2.43M

-136.41%-25.57M

-325.92%-25.41M

Cash from discontinued investing activities

Investing cash flow

67.10%-6.17M

-946.90%-44.13M

-453.55%-7.82M

100.87%208K

145.59%11.53M

-1,236.63%-18.74M

472.75%5.21M

105.67%2.21M

-136.28%-23.96M

-416.16%-25.29M

Financing cash flow

Cash flow from continuing financing activities

-101.30%-299K

1,013.39%73.68M

636,100.00%25.44M

-14.17%37.06M

-82.54%7.47M

448.48%22.98M

274.99%6.62M

-4K

73.66%43.17M

161.87%42.77M

Net issuance payments of debt

--0

--20M

----

--0

----

Net common stock issuance

--0

1,012.76%73.7M

--6.42M

-20.38%37.39M

-81.80%7.79M

448.58%22.98M

--6.62M

--0

95.42%46.96M

161.90%42.77M

Net preferred stock issuance

----

--0

----

---3.78M

--0

Proceeds from stock option exercised by employees

----

-3,540.00%-182K

----

-100.60%-5K

---5K

Net other financing activities

-7,375.00%-299K

-180.00%-14K

-24,325.00%-977K

---150K

---137K

---4K

---5K

---4K

----

Cash from discontinued financing activities

Financing cash flow

-101.30%-299K

1,013.39%73.68M

636,100.00%25.44M

-14.17%37.06M

-82.54%7.47M

448.48%22.98M

274.99%6.62M

---4K

73.66%43.17M

161.87%42.77M

Net cash flow

Beginning cash position

429.70%34.76M

256.64%17.9M

1.76%14.81M

-62.52%14.56M

-54.39%5.05M

-45.42%6.56M

-80.86%5.02M

-62.52%14.56M

186.12%38.83M

-75.26%11.07M

Current changes in cash

-1,135.96%-18.7M

991.78%16.87M

132.35%3.09M

101.05%256K

180.17%9.76M

-58.76%-1.51M

110.89%1.55M

24.38%-9.54M

-196.10%-24.27M

158.78%3.48M

End cash Position

218.10%16.06M

429.70%34.76M

256.64%17.9M

1.76%14.81M

-54.39%5.05M

-45.42%6.56M

-80.86%5.02M

-62.52%14.56M

Free cash flow

-118.27%-12.64M

-29.85%-13.4M

-27.60%-15.26M

14.38%-37.34M

33.85%-9.27M

14.77%-5.79M

-14.46%-10.32M

13.26%-11.96M

37.53%-43.61M

58.16%-14.02M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-112.91%-12.23M	-23.34%-12.68M	-23.79%-14.54M	14.89%-37.01M	34.00%-9.24M	15.39%-5.75M	-14.10%-10.28M	14.20%-11.74M	33.78%-43.48M	53.76%-13.99M
Net income from continuing operations	-155.74%-30.27M	144.47%7.41M	-246.74%-31.58M	-36.51%-54.19M	-132.99%-16.59M	-83.96%-11.84M	-306.49%-16.65M	58.69%-9.11M	53.26%-39.7M	84.75%-7.12M
Operating gains losses	1,270.34%15.16M	-427.54%-24.93M	863.84%17.3M	218.29%10.68M	189.65%4.23M	136.44%1.11M	400.71%7.61M	-280.77%-2.27M	-413.42%-9.03M	---4.71M
Depreciation and amortization	-3.86%722K	-18.26%685K	-18.47%724K	-30.13%3.2M	-28.54%721K	-30.78%751K	-38.83%838K	-20.22%888K	2.53%4.58M	-15.64%1.01M
Other non cash items	69.65%531K	160.54%383K	1,782.35%286K	-8.99%324K	93.34%-119K	146.46%313K	110.88%147K	-100.50%-17K	105.43%356K	-2,568.66%-1.79M
Change In working capital	-107.53%-178K	177.64%2.45M	-39.94%-2.82M	69.65%-1.79M	125.35%1.02M	183.33%2.36M	-101.21%-3.15M	-74.29%-2.01M	67.74%-5.89M	79.11%-4M
-Change in receivables	-99.23%27K	110.10%552K	436.00%252K	-172.58%-2.04M	-102.33%-20K	97.64%3.52M	-93.28%-5.46M	-102.50%-75K	193.73%2.81M	128.63%859K
-Change in prepaid assets	-10.50%213K	40.52%593K	-2.75%-1.23M	-107.94%-155K	-26.30%384K	-51.92%238K	-24.37%422K	-416.36%-1.2M	490.03%1.95M	135.44%521K
-Change in payables and accrued expense	92.64%-79K	-29.07%1.57M	-349.47%-1.69M	122.41%2.04M	132.11%1.28M	6.20%-1.07M	215.10%2.21M	91.97%-376K	41.57%-9.11M	72.93%-3.98M
-Change in other current assets	138.71%12K	255.56%14K	391.07%163K	-287.20%-234K	-500.00%-138K	---31K	---9K	-137.84%-56K	1,885.71%125K	-243.75%-23K
-Change in other current liabilities	-21.88%-351K	10.83%-280K	-0.98%-310K	16.43%-1.4M	64.44%-490K	2.70%-288K	---314K	---307K	---1.67M	---1.38M
Cash from discontinued investing activities
Operating cash flow	-112.91%-12.23M	-23.34%-12.68M	-23.79%-14.54M	14.89%-37.01M	34.00%-9.24M	15.39%-5.75M	-14.10%-10.28M	14.20%-11.74M	33.78%-43.48M	53.76%-13.99M
Investing cash flow
Cash flow from continuing investing activities	67.10%-6.17M	-946.90%-44.13M	-453.55%-7.82M	100.87%208K	145.59%11.53M	-1,236.63%-18.74M	472.75%5.21M	105.67%2.21M	-136.28%-23.96M	-416.16%-25.29M
Capital expenditure reported	-818.18%-404K	-2,121.88%-711K	-232.57%-725K	-154.62%-331K	-48.00%-37K	-2,100.00%-44K	---32K	-111.65%-218K	96.87%-130K	99.23%-25K
Net PPE purchase and sale	--0	----	----	-88.24%204K	-88.19%17K	-92.23%8K	----	----	--1.73M	--144K
Net investment purchase and sale	69.19%-5.76M	-957.80%-43.44M	-391.97%-7.09M	101.31%335K	145.45%11.55M	-1,308.46%-18.71M	275.53%5.06M	106.20%2.43M	-136.41%-25.57M	-325.92%-25.41M
Cash from discontinued investing activities
Investing cash flow	67.10%-6.17M	-946.90%-44.13M	-453.55%-7.82M	100.87%208K	145.59%11.53M	-1,236.63%-18.74M	472.75%5.21M	105.67%2.21M	-136.28%-23.96M	-416.16%-25.29M
Financing cash flow
Cash flow from continuing financing activities	-101.30%-299K	1,013.39%73.68M	636,100.00%25.44M	-14.17%37.06M	-82.54%7.47M	448.48%22.98M	274.99%6.62M	-4K	73.66%43.17M	161.87%42.77M
Net issuance payments of debt	--0	--0	--20M	----	----	--0	--0	--0	----	----
Net common stock issuance	--0	1,012.76%73.7M	--6.42M	-20.38%37.39M	-81.80%7.79M	448.58%22.98M	--6.62M	--0	95.42%46.96M	161.90%42.77M
Net preferred stock issuance	----	----	----	--0	----	----	----	----	---3.78M	--0
Proceeds from stock option exercised by employees	----	----	----	-3,540.00%-182K	----	----	----	----	-100.60%-5K	---5K
Net other financing activities	-7,375.00%-299K	-180.00%-14K	-24,325.00%-977K	---150K	---137K	---4K	---5K	---4K	----	----
Cash from discontinued financing activities
Financing cash flow	-101.30%-299K	1,013.39%73.68M	636,100.00%25.44M	-14.17%37.06M	-82.54%7.47M	448.48%22.98M	274.99%6.62M	---4K	73.66%43.17M	161.87%42.77M
Net cash flow
Beginning cash position	429.70%34.76M	256.64%17.9M	1.76%14.81M	-62.52%14.56M	-54.39%5.05M	-45.42%6.56M	-80.86%5.02M	-62.52%14.56M	186.12%38.83M	-75.26%11.07M
Current changes in cash	-1,135.96%-18.7M	991.78%16.87M	132.35%3.09M	101.05%256K	180.17%9.76M	-58.76%-1.51M	110.89%1.55M	24.38%-9.54M	-196.10%-24.27M	158.78%3.48M
End cash Position	218.10%16.06M	429.70%34.76M	256.64%17.9M	1.76%14.81M	1.76%14.81M	-54.39%5.05M	-45.42%6.56M	-80.86%5.02M	-62.52%14.56M	-62.52%14.56M
Free cash flow	-118.27%-12.64M	-29.85%-13.4M	-27.60%-15.26M	14.38%-37.34M	33.85%-9.27M	14.77%-5.79M	-14.46%-10.32M	13.26%-11.96M	37.53%-43.61M	58.16%-14.02M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data